|
시장보고서
상품코드
1983203
인간 융모성 고나도트로핀(HCG) 시장 : 제품 유형별, 치료 용도별, 유통 채널별, 지역별Human Chorionic Gonadotropin (HCG) Market, By Product Type, By Therapeutic Application, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
인간 융모성 고나도트로핀(HCG) 시장은 2026년에 29억 6,000만 달러로 추정되고 있으며, 2033년까지 31억 2,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 3.68%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 29억 6,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2032년) | 3.68% | 예측 금액(2033년) | 31억 2,000만 달러 |
인간 융모성 성선자극호르몬(HCG)은 수정란이 자궁에 착상한 후 태반에서 분비되는 호르몬입니다. 이 호르몬은 난자의 정상적인 발육을 돕고 난소에서 배란을 촉진하는 역할도 합니다. HCG는 주로 불임 치료를 받는 여성의 배란을 유도하는 데 사용됩니다. 또한 남성의 경우 주로 정자 수 증가를 목적으로 사용되며, 뇌하수체 장애 및 기타 질환으로 인해 젊은 남성의 고환이 자연적으로 음낭으로 내려오지 않는 경우에도 사용됩니다. HCG는 보통 피하 또는 근육 주사로 투여됩니다. HCG는 산부인과 의사나 약사의 지도하에 집에서도 투여할 수 있습니다. HCG의 농도는 소변검사나 혈액검사를 통해 측정할 수 있습니다. 특정 검사 결과에 따라 농도의 정확한 측정이 가능합니다. 이 검사들은 주로 임신의 확인이나 확인 또는 선천성 기형을 판단하기 위한 선별 검사로 사용됩니다. 이 호르몬은 황체를 자극하여 임신을 유지하기 위해 프로게스테론을 생산하게 합니다.
시장 역학
시장내 주요 기업의 제휴 및 인수와 같은 비유기적 전략의 채택이 증가함에 따라 예측 기간 중 시장 성장을 촉진할 것으로 예측됩니다. 예를 들어 2021년 1월 과학기술 기업 머크(Merck &Co., Inc.)는 의료 기술 기업 로열 Philips(Royal Philips)와 고도로 개인화된 불임 치료를 위한 임상용 디지털 솔루션을 개발하기 위해 다년간의 파트너십을 체결했습니다. 다년간의 파트너십을 발표했습니다.
이 보고서의 주요 특징
- 세계의 인간 융모성 성선자극호르몬(HCG) 시장에 대해 조사 분석했으며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트을 제공합니다.
- 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 인간 융모성 성선자극호르몬(HCG) 시장의 주요 기업 개요을 제공합니다.
- 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 인간 융모성 성선자극호르몬(HCG) 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 인간 융모성 성선자극호르몬(HCG) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 인간 융모성 고나도트로핀(HCG) 시장 : 제품 유형별(2026-2033년)
제5장 세계의 인간 융모성 고나도트로핀(HCG) 시장 : 치료 용도별(2026-2033년)
제6장 세계의 인간 융모성 고나도트로핀(HCG) 시장 : 유통 채널별(2026-2033년)
제7장 세계의 인간 융모성 고나도트로핀(HCG) 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 분석 방법
KSA 26.04.20Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at USD 2.96 Bn in 2026 and is expected to reach USD 3.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.68% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.96 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.68% | 2033 Value Projection: | USD 3.12 Bn |
Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.
Market Dynamics
The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.
Key features of the study
- This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
- Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.
Market Segmentation
- By Product Type
- Human Chorionic Gonadotropin
- Recombinant Human Chorionic Gonadotropin
- By Therapeutic Application
- Male Hypogonadism
- Female Infertility Treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
- Chronic Pain
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- Ferring B.V.
- Fresenius SE & Co.KGaA,
- Lupin
- Sun Pharmaceutical Industries Ltd.
- Lee BioSolutions
- Serum Institute of India Pvt. Ltd.
- Scripps Laboratories
- Sanzyme Biologics Pvt. Ltd.
- VHB Medi Sciences Limited Bharat Serums
- Vaccines Limited (BSV)
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Therapeutic Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Human Chorionic Gonadotropin
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Recombinant Human Chorionic Gonadotropin
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Male Hypogonadism
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Female Infertility Treatment
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oligospermic Treatment
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cryptorchidism Treatment
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Chronic Pain
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Merck & Co., Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Ferring B.V.,Fresenius SE & Co.KGaA
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Lupin
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Lee BioSolutions
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Serum Institute of India Pvt. Ltd
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Scripps Laboratories
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Sanzyme Biologics Pvt. Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV)
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Zydus Lifesciences Ltd
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Corona Remedies Pvt. Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Merck & Co., Inc.
9. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. Section
- References
- Research Methodology
- About Us and Sales Contact
